CHOP and Penn Landmark

"The researchers at Children’s Hospital of Philadelphia (CHOP) and Penn Medicine behind the landmark customized CRISPR gene editing therapy that helped treat a patient’s ultra-rare metabolic disorder are planning an entirely new type of clinical trial to make this technology more accessible to patients with other rare diseases."https://www.chop.edu/news/researchers-behind-personalized-crispr-therapy-plan-launch-new-type-clinical-trial?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4c92f5d78644b3ac5d5b4